GENEVA, Aug. 7 -- AMGEN RESEARCH (MUNICH) GMBH filed a patent application (EP2026/052518) for “BLINATUMOMAB WITH LOW-INTENSITY-CHEMOTHERAPY FOR USE IN TREATING ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA”. With publication no. WO/2026/162764, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....